PUBLISHER: Grand View Research | PRODUCT CODE: 2067633
PUBLISHER: Grand View Research | PRODUCT CODE: 2067633
The global pet light therapy devices market size was estimated at USD 67.5 million in 2025 and is projected to reach USD 148.5 million by 2033, growing at a CAGR of 10.6% from 2026 to 2033. The market is advancing due to increasing demand for red light therapy devices for pets, rising technological advancements in pet therapy devices, and growing adoption of at-home pet rehabilitation devices.
The expanding global pet population is a significant market driver. As of 2025, global pet ownership has surpassed one billion animals, with over 900 million pet dogs and 370 million pet cats recorded worldwide. According to a report, in the U.S., approximately 66% of households, which is 86.9 million homes, owned at least one pet as of 2025. This population scale directly translates into a sizable addressable patient base for therapeutic veterinary devices. Similarly, pet humanization is accelerating owner willingness to pursue non-invasive, drug-free treatment modalities. Photobiomodulation therapy, which operates through red and near-infrared wavelengths typically ranging from 600 nm to 1,000+ nm, has gained momentum as a clinically relevant intervention for musculoskeletal conditions, chronic pain, and wound healing in companion animals. These are high-prevalence conditions across aging dog and cat populations, where osteoarthritis, cruciate ligament injuries, intervertebral disc disease, and post-surgical inflammation represent recurring therapeutic indications.
In addition, rapid innovation in device engineering is materially expanding the functional scope and commercial addressability of the market. Manufacturers are transitioning from single-modality, single-wavelength systems to multi-wavelength platforms capable of delivering targeted therapeutic outputs across distinct tissue depths. This multi-spectral capability enables a single device to address a broader set of clinical indications, improving per-unit utility for both veterinary clinics and home users. In addition, wearable formats represent a particularly significant product innovation. LED-integrated wraps, coats, and straps allow continuous, hands-free therapy delivery, improving treatment compliance in animals that resist stationary or handheld device protocols. For instance, the HEALED LED Wrap, engineered specifically for canine pain management, employs clinically validated red and near-infrared wavelengths to reduce inflammatory markers and inhibit peripheral nerve conduction, targeting conditions including arthritis, cruciate ligament injury, post-operative pain, and neuropathic pain without requiring clinical oversight during each session.
In addition, the shift toward home-based pet rehabilitation is generating sustained demand for consumer-facing light therapy devices. Pet owners are increasingly seeking alternatives to frequent, high-cost veterinary clinic visits, particularly for chronic conditions requiring ongoing therapeutic management. Light therapy, delivered through LED-based handheld devices and therapy mats, offers a cost-effective and operationally accessible modality for maintaining treatment continuity between clinical sessions.
Moreover, LED devices have accelerated in the home-use segment due to their safety profile relative to laser systems. LED devices use non-coherent, broad-spectrum light that reduces tissue damage risk and does not require specialized handling training. This distinction makes LED technology practically suitable for unsupervised home administration by pet owners, supporting daily or multi-session protocols for conditions such as joint stiffness, chronic arthritis, and superficial wound healing.
In addition, the expansion of pet insurance coverage is supporting at-home device adoption. In the U.S., approximately 6.4 million pets were insured as of 2024, representing nearly 10% of the national pet population, with total insurance premiums reaching USD 4.7 billion by year-end 2024. Growing financial coverage for pet healthcare creates greater spending capacity among owners for supplementary therapeutic devices. For instance, established at-home platforms such as LumaSoothe 2, offering dual treatment modes for joint and skin conditions, respectively, illustrate the commercial viability of this segment, as LED devices increasingly function as routine home-care complements to professional veterinary treatment rather than standalone clinical substitutes.
Global Pet Light Therapy Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pet light therapy devices market report based on product, technology, pet, application, end use, and region: